June 15, 2026 12:42 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Tragedy in the skies: Five IAF personnel killed in AN-32 crash in Assam | 'Ask probe officers whether I hid anything': Abhishek Banerjee hits back after pre-dawn police search | Police storm Abhishek Banerjee's house at 3 am tracking aide, Mamata arrives; seizure list says 'NIL' | Big boost for India's security: DRDO successfully tests advanced missile shield | Indian-origin man jailed for 34 years in UK over horrific kidnap, torture and rape case | Mamata's nightmare deepens! Saayoni Ghosh, Dev, Rachana Banerjee among 19 rebel MPs seeking TMC split | Trump claims US 'ended war with Iran', Tehran yet to confirm a deal | Heartbreak for Indian sports: Manu Bhaker's mentor Jaspal Rana passes away at 49 | Three Indian seafarers, missing after US strike on tanker near Oman, confirmed dead | 'Choose your side': TMC MP Kalyan Banerjee's ultimatum to Mamata in open revolt against Abhishek

Vicks Action 500 Extra banned

| | Mar 15, 2016, at 06:12 pm
Mumbai, Mar 15 (IBNS) After Corex and Phensedyl it is now Vicks Action 500 Extra as FMCG major Procter and Gamble (P&G) has discontinued manufacture and sale of its popular brand of cold and flu pill with immediate effect after the government banned fixed dose combination drugs.
 "The Government of India has prohibited the manufacture for sale, sale and distribution of fixed dose combination drugs (Paracetamol + Phenylephrine + Caffeine) with immediate effect," Pfizer   said in a BSE filing.
 
 "Our product 'Vicks Action 500 Extra' has the same fixed dose combination and gets covered under notification. we have discontinued the manufacture and sale of all SKUs of 'Vicks Action 500 Extra with immediate effect." 
 
On Monday,  Pfizer and Abbott stopped sale of their popular cough syrups Corex and Phensedyl respectively, after the government banned over 300 fixed dose combinations (FDCs) drugs. 
 
Corex had garnered sales of Rs 176 crore in the nine-month period ended December 31. Pfizer admitted that the  government's move will have an adverse impact on it. 

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.